von Tobias Borgers | Apr 26, 2023 | Markt
This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style. The FDA has issued the ICH final guidance, Q13 Continuous Manufacturing of Drug Substances and Drug Products. The guidance, which was...
von Tobias Borgers | Apr 10, 2023 | Bayer
Pharma-Chef kritisiert Regulationswut: „In Deutschland fehlt der Zugang zu Forschungsdaten“ Der Pharma-Chef von Bayer, Stefan Oelrich, sieht Deutschland forschungspolitisch auf einem gefährlichen Weg. Noch habe er Hoffnung, sagte Oelrich im Tagesspiegel-Interview ,...
von Tobias Borgers | Apr 9, 2023 | Markt
Sigma Planning Corp has recently announced a significant increase in its holdings of GSK plc (NYSE:GSK), one of the leading healthcare companies worldwide. The institutional investor in its most recent disclosure with the SEC stated that it had elevated its holdings...
von Tobias Borgers | Mrz 8, 2023 | Bayer
Life sciences giant Bayer is using the latest technology to drive change in three very distinct areas of its business: agriculture, pharma, and personal healthcare. Training and developing a new breed of leader is paramount to success, Sarena Lin, the company’s Chief...
von Tobias Borgers | Feb 26, 2023 | Markt
Around 2,700 companies from around the world will meet in Düsseldorf from 4 -10 May 2023 for interpack After delays and disruptions because of the Covid-19 pandemic, Interpack, an international packaging fair for food, beverages, confectionery, bakery, pharmaceutics,...
